The Rest Of Europe Biopreservation Market was valued at $71.2 Million in 2024 and projected to reach to $97.6 Million by 2029, representing a compound annual growth rate of 6.5%. Rest Of Europe's biopreservation market is positioned for steady growth as healthcare institutions increasingly recognize the value of advanced preservation technologies for cell therapy, tissue engineering, and regenerative medicine applications.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Europe biopreservation market valued at USD 71.2 million in 2024, projected to reach USD 97.6 million by 2029, demonstrating consistent market expansion and investment opportunities.
The region exhibits a 6.5% CAGR through 2029, reflecting moderate but sustainable growth driven by increasing healthcare infrastructure investments and regulatory support for biobanking initiatives.
Rising adoption of biopreservation technologies in Rest Of Europe is fueled by growing demand for advanced cell and tissue banking solutions supporting regenerative medicine and personalized healthcare applications.
Expansion of clinical research capabilities across Rest Of Europe countries is driving biopreservation technology adoption, with increased focus on sample preservation for long-term research studies and therapeutic development.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | BIOPRESERVATION EQUIPMENT (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.8% from 2024 to 2029 |
| Largest Segment | BIOPRESERVATION MEDIA (Product) |
| Market Size Base Year (Billions) | ~USD 4.45 (2024) |
| Revenue Forecast (Billions) | ~USD 7.1 (2029) |
| Segments Covered | Product, Type, Biospecimen, Application, End User, Transplant Type |
6 segment dimensions are covered across the global market.
Rest Of Europe's biopreservation market was valued at USD 71.2 million in 2024 and is expected to grow to USD 97.6 million by 2029.
Rest Of Europe biopreservation market is projected to grow at a CAGR of 6.5% from 2024 to 2029.
Rest Of Europe's market growth is driven by increasing demand for cell and tissue banking, regenerative medicine applications, rising pharmaceutical R&D investments, and expanding biobanking infrastructure.
Rest Of Europe is experiencing increased adoption of cryopreservation and controlled-rate freezing technologies across research institutions and clinical facilities.
Rest Of Europe's biopreservation demand is driven by pharmaceutical companies, biotechnology firms, academic research institutions, contract research organizations, and clinical laboratories.
The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are:
The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.
The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:

Note 1: *Others include sales managers, marketing managers, and product managers.
Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.
Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.
MarketsandMarkets offers the following customizations for this market report:
Full forecast, segment splits, and company analysis for all Biopreservation Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report